| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1 Physiology and Biophysics and 2 Medicine (Cardiology), Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4970
Smooth muscle is generally grouped into two classes of differing contractile properties. Tonic smooth muscles show slow rates of force activation and relaxation and slow speeds of shortening (Vmax) but force maintenance, whereas phasic smooth muscles show poor force maintenance but have fast Vmax and rapid rates of force activation and relaxation. We characterized the development of gizzard and aortic smooth muscle in embryonic chicks to identify the cellular determinants that define phasic (gizzard) and tonic (aortic) contractile properties. Early during development, tonic contractile properties are the default for both tissues. The gizzard develops phasic contractile properties between embryonic days (ED) 12 and 20, characterized primarily by rapid rates of force activation and relaxation compared with the aorta. The rapid rate of force activation correlates with expression of the acidic isoform of the 17-kDa essential myosin light chain (MLC17a). Previous data from in vitro motility assays (Rover AS, Frezon Y, and Trybus KM. J Muscle Res Cell Motil 18: 103-110, 1997) have postulated that myosin heavy chain (MHC) isoform expression is a determinant for Vmax in intact tissues. In the current study, differences in Vmax did not correlate with previously published differences in MHC or MLC17a isoforms. Rather, Vmax was increased with thiophosphorylation of the 20-kDa regulatory myosin light chain (MLC20) in the gizzard, suggesting that a significant internal load exists. Furthermore, Vmax in the gizzard increased during postnatal development without changes in MHC or MLC17 isoforms. Although the rate of MLC20 phosphorylation was similar at ED 20, the rate of MLC20 dephosphorylation was significantly higher in the gizzard versus the aorta, correlating with expression of the M130 isoform of the myosin binding subunit in the myosin light chain phosphatase (MLCP) holoenzyme. These results indicate that unique MLCP and MLC17 isoform expression marks the phasic contractile phenotype.
force; 17-kilodalton myosin light chain; phasic contractile properties; tonic smooth muscle; development
This article has been cited by other articles:
|
|
 |
|
  S. L. Yuen, O. Ogut, and F. V. Brozovich Nonmuscle myosin is regulated during smooth muscle contraction Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H191 - H199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shukla and S. A. Fisher Tra2{beta} As a Novel Mediator of Vascular Smooth Muscle Diversification Circ. Res., August 29, 2008; 103(5): 485 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. SHUKLA, F. DEL GATTO-KONCZAK, R. BREATHNACH, and S. A. FISHER Competition of PTB with TIA proteins for binding to a U-rich cis-element determines tissue-specific splicing of the myosin phosphatase targeting subunit 1 RNA, November 1, 2005; 11(11): 1725 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ekman, K. Fagher, M. Wede, K. Stakeberg, and A. Arner Decreased Phosphatase Activity, Increased Ca2+ Sensitivity, and Myosin Light Chain Phosphorylation in Urinary Bladder Smooth Muscle of Newborn Mice J. Gen. Physiol., January 31, 2005; 125(2): 187 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. SOMLYO and A. V. SOMLYO Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase Physiol Rev, October 1, 2003; 83(4): 1325 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wrayzx, K. Jones, S. Kupittayanant, Y. Li, A. Matthew, E. Monir-Bishty, K. Noble, S. J. Pierce, S. Quenby, and A. V. Shmygol Calcium Signaling and Uterine Contractility Reproductive Sciences, July 1, 2003; 10(5): 252 - 264. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Karagiannis, G. J Babu, M. Periasamy, and F. V Brozovich The Smooth Muscle Myosin Seven Amino Acid Heavy Chain Insert's Kinetic Role in the Crossbridge Cycle for Mouse Bladder J. Physiol., March 1, 2003; 547(2): 463 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Hai, G. Sadowska, L. Francois, and B. S. Stonestreet Maternal dexamethasone treatment alters myosin isoform expression and contractile dynamics in fetal arteries Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1743 - H1749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S.M Rensen, V.L.J.L Thijssen, C.J De Vries, P.A Doevendans, S.D Detera-Wadleigh, and G.J.J.M Van Eys Expression of the smoothelin gene is mediated by alternative promoters Cardiovasc Res, September 1, 2002; 55(4): 850 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Khatri, K. M. Joyce, F. V. Brozovich, and S. A. Fisher Role of Myosin Phosphatase Isoforms in cGMP-mediated Smooth Muscle Relaxation J. Biol. Chem., September 28, 2001; 276(40): 37250 - 37257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Richards, O. Ogut, and F. V. Brozovich Agonist-induced Force Enhancement. THE ROLE OF ISOFORMS AND PHOSPHORYLATION OF THE MYOSIN-TARGETING SUBUNIT OF MYOSIN LIGHT CHAIN PHOSPHATASE J. Biol. Chem., February 1, 2002; 277(6): 4422 - 4427. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
